Insights
Short, frequent notes from the desk, what we are reading in the filings, the funding and the science.
GLP-1 exclusivity is not one patent cliff. It is five, each governed by a different molecule, pathway and jurisdiction. Read molecule by molecule, the way we build it for a client making a real market-entry decision.
Signals, mental models and analysis, sent when it matters, never as noise.
